Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00033234
DRKS00033234
Recruiting
Not Applicable

Vascular Endothelial Growth Factor, thrombelastography and coagulation in the context of etiology, outcome and clinical course of patients after circulatory arrest - VEPCA

BG-Klinikum Unfallkrankenhaus Berlin0 sites150 target enrollmentDecember 18, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsI46Cardiac arrest

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
I46
Sponsor
BG-Klinikum Unfallkrankenhaus Berlin
Enrollment
150
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 18, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
BG-Klinikum Unfallkrankenhaus Berlin

Eligibility Criteria

Inclusion Criteria

  • •Return of spontaneous circulation or decision to initiate ECLS (extracorporeal life support)

Exclusion Criteria

  • •\- Age \< 18 years
  • •\- pregnancy
  • •\- Patient, legal guardians or authorized representatives do not give informed consent or relatives indicate that the presumed patient wishes contradict a participation.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Association of Vascular Endothelial Growth Factor (VEGF) serum levels And Ankylosing Spondylitis in Egyptian patientsAnkylosing spondylitis
PACTR202210522771809Hossam salaheldin Abdelmohsen Labib70
Recruiting
Phase 3
A clinical trial to study the levels of vascular endothelial growth factor in the fluid in the front part of the eye in cases of occlusion of venous supply of the eye and to correlate with the clinical features and nerve thickness as obtained by scanning and nerve function tests
CTRI/2012/12/003270arayana Nethralaya30
Completed
Not Applicable
The effect of vascular endothelial growth factor taking tube shunt for neovascular glaucomaneovascular glaucoma
JPRN-UMIN000018407Yokohama City university center hospital the department of opthalmology20
Active, not recruiting
Phase 1
Vascular endothelial growth factor concentration in the blod after treatment with aflibercept in the human eye.
EUCTR2014-000103-27-NO
Completed
Not Applicable
Effect of anti-vascular endothelial growth factor (VEGF) drugs in chronic central serous chorioretinopathy (CSC)chronic central serous chorioretinopathy
JPRN-UMIN000014110Kansai medical university takii hospital10